 <h1>Picato Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ingenol topical</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ingenol topical. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Picato.</p><h2>In Summary</h2><p><b>Common side effects of Picato include:</b> dermal ulcer, localized vesiculation, skin erosion, swelling of skin, and erythema of skin.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ingenol topical: topical application gel/jelly</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ingenol topical (the active ingredient contained in Picato) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking ingenol topical:</p><p>
<i>More common</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>pain and itching at the application site</li>
<li>redness of the skin (severe)</li>
<li>skin ulcers</li>
<li>swelling of the skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Burning, dry, or itching eyes</li>
<li>discharge or excessive tearing</li>
<li>eye pain</li>
<li>infection at the application site</li>
<li>redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>swelling around the eyes</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ingenol topical may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Flaking or scaling of the skin</li>
<li>redness of the skin (mild)</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Headache</li>
</ul><p>
<!-- end topical application gel/jelly --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ingenol topical: topical gel</i></p><h3>General</h3><p>The most commonly reported side effects were local skin responses including erythema, flaking/scaling, crusting, swelling, vesiculation/postulation, and erosion.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Application site erythema (up to 94%), application site exfoliation (up to 90%), application site scab (up to 80%), application site swelling (up to 79%), application site erosion/ulceration (up to 32%), application site vesicles (up to 20%), application site pain (including application site burning) (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Application site pruritus, application site irritation</p>
<p><b>Uncommon</b> (0.1% to 1%): Application site discharge, application site paresthesia, application site ulcer, application site warmth<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Flaking/scaling (85%), crusting (80%), vesiculation/postulation (56%)</p>
<p><b>Postmarketing reports</b>: Allergic contact dermatitis, application site pigmentation changes, application site scarring, chemical conjunctivitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Application site pustules (up to 43%)</p>
<p><b>Common</b> (1% to 10%): Application site infection</p>
<p><b>Postmarketing reports</b>: Herpes zoster<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Eye lid edema, periorbital edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Eyelid pain</p>
<p><b>Frequency not reported</b>: Chemical conjunctivitis, corneal burn, eyelid ptosis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Swelling (79%)<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Picato (ingenol topical)." Leo Pharma Inc, Parsippany, NY. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Picato (ingenol topical)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>19 Reviews</li>
<li>Drug class: topical antineoplastics</li>
<li>FDA Alerts (1)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Picato &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Actinic Keratosis</li>
<li>Keratosis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ingenol topical: topical gel</i></p><h3>General</h3><p>The most commonly reported side effects were local skin responses including erythema, flaking/scaling, crusting, swelling, vesiculation/postulation, and erosion.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Application site erythema (up to 94%), application site exfoliation (up to 90%), application site scab (up to 80%), application site swelling (up to 79%), application site erosion/ulceration (up to 32%), application site vesicles (up to 20%), application site pain (including application site burning) (up to 15%)</p><p><b>Common</b> (1% to 10%): Application site pruritus, application site irritation</p><p><b>Uncommon</b> (0.1% to 1%): Application site discharge, application site paresthesia, application site ulcer, application site warmth<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Flaking/scaling (85%), crusting (80%), vesiculation/postulation (56%)</p><p><b>Postmarketing reports</b>: Allergic contact dermatitis, application site pigmentation changes, application site scarring, chemical conjunctivitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Application site pustules (up to 43%)</p><p><b>Common</b> (1% to 10%): Application site infection</p><p><b>Postmarketing reports</b>: Herpes zoster<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Eye lid edema, periorbital edema</p><p><b>Uncommon</b> (0.1% to 1%): Eyelid pain</p><p><b>Frequency not reported</b>: Chemical conjunctivitis, corneal burn, eyelid ptosis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Swelling (79%)<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Picato (ingenol topical)." Leo Pharma Inc, Parsippany, NY. </p><h2>More about Picato (ingenol topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>19 Reviews</li>
<li>Drug class: topical antineoplastics</li>
<li>FDA Alerts (1)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Picato &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Actinic Keratosis</li>
<li>Keratosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>